Lineage Cell Therapeutics In shares owned by CIBC World Markets
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by CIBC World Markets
from 13F filings
Historical chart of CIBC World Markets investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by CIBC World Markets consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by CIBC World Markets
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $79k | 47k | 1.67 |
| 2025-09-30 | $80k | 47k | 1.69 |
| 2025-06-30 | $43k | 47k | 0.91 |
| 2025-03-31 | $21k | 46k | 0.45 |
| 2024-12-31 | $23k | 46k | 0.50 |
| 2024-09-30 | $42k | 46k | 0.91 |
| 2024-06-30 | $46k | 46k | 1.00 |
| 2024-03-31 | $68k | 46k | 1.48 |
| 2023-09-30 | $54k | 46k | 1.17 |